Akin to other chemotherapeutics, a combination of BRAF and MEK inhibitors (BRAFi + MEKi), which activate caspase-3, have recently been reported to induce pyroptotic cell death in GSDME expressing cancers (Figure 1C) [67]. The gene discussed is CASP3; the disease is cancer.